- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00356317
Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia
A Culturally Based Family Therapy for Schizophrenia
Study Overview
Status
Conditions
Detailed Description
Schizophrenia is a disabling mental disorder that affects approximately 1% of the population worldwide. People with schizophrenia frequently experience hallucinations, delusions, disordered thinking, movement disorders, emotional numbness, social withdrawal, and cognitive deficits. These symptoms can hinder a person's ability to perform everyday functions, such as hold a job and maintain normal social relationships. When combined with medication, family-oriented therapy interventions have been beneficial for people with schizophrenia. There are few programs, however, that are tailored to the needs of minorities. With the rising number of minority populations in the U.S., it is important to develop psychotherapy interventions that are designed specifically for these groups. This study will evaluate the effectiveness of a culturally based family therapy intervention in improving treatment outcome in people with schizophrenia.
Participants in this 12-month, open label study will first attend a 2-hour screening visit, at which information will be gathered regarding coping styles, spirituality, and expressed emotion. Participants will then be randomly assigned to receive either culturally based therapy or treatment as usual. Although the culturally based therapy will be tailored to the needs and values of Hispanics, people who are not Hispanic will not be excluded. The culturally based therapy will entail 15 weekly therapy sessions, which will focus on family unity, psychoeducation, spirituality, communication skills, and problem-solving. The group receiving treatment as usual will attend 3 weekly psychoeducation sessions that will focus on informing participants about schizophrenia. Outcomes for both groups will be assessed upon completion of treatment and at follow-up visits at Months 6 and 12.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Florida
-
Coral Gables, Florida, United States, 33146
- University of Miami
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
For participants with schizophrenia or schizoaffective disorder:
- Diagnosis of schizophrenia or schizoaffective disorder
- Currently taking medication
- 18 or older
For all participants:
- Two or more family members, including patient, are available for participation (therapy can be conducted if patient is not available, as long as two other family members are interested in participating)
- Family members must be at least 13 years old
Exclusion Criteria:
- N/A
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
Participants will receive a 15-week family therapy
|
This family therapy consists of 15 video-taped, therapy sessions, each lasting approximately 75 minutes.
The 15-session treatment will be broken down into five segments (each lasting approximately three sessions) with the following goals: 1) Fortify a strong sense of family unity; 2) educate about schizophrenia; 3) foster adaptive use of cultural, spiritual and/or existential beliefs in conceptualizing and coming to terms with schizophrenia; 4) teach effective communication training techniques; and 5) and teach useful problem solving strategies.
|
|
Active Comparator: 2
Participants will receive a 3-week family therapy (treatment as usual)
|
This family therapy consists of three weekly sessions focusing on education about schizophrenia.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Schizophrenia symptom severity
Time Frame: Measured immediately post-treatment and at Months 6 and 12
|
Measured immediately post-treatment and at Months 6 and 12
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Symptoms of depression, anxiety, and stress
Time Frame: Measured immediately post-treatment and at Months 6 and 12
|
Measured immediately post-treatment and at Months 6 and 12
|
|
Family functioning
Time Frame: Measured immediately post-treatment and at Months 6 and 12
|
Measured immediately post-treatment and at Months 6 and 12
|
|
Cultural Identity
Time Frame: Measured immediately post-treatment and at Months 6 and 12
|
Measured immediately post-treatment and at Months 6 and 12
|
|
Coping styles
Time Frame: Measured immediately post-treatment and at Months 6 and 12
|
Measured immediately post-treatment and at Months 6 and 12
|
|
Religiosity/Spirituality
Time Frame: Measured immediately post-treatment and at Months 6 and 12
|
Measured immediately post-treatment and at Months 6 and 12
|
|
Alcohol and Drug Use
Time Frame: Measured immediately post-treatment and at Months 6 and 12
|
Measured immediately post-treatment and at Months 6 and 12
|
|
Knowledge and knowledge about schizophrenia
Time Frame: Measured immediately post-treatment and at Months 6 and 12
|
Measured immediately post-treatment and at Months 6 and 12
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Amy Weisman, PhD, University of Miami
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R34MH071250 (U.S. NIH Grant/Contract)
- DSIR 83-ATAP (NIMH/DSIR)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.